Integrating tumor hypoxic sensing and photothermal therapy using a miniaturized fiber-optic theranostic probe

Author:

Ran Yang1ORCID,Jin Fangzhou1,Xu Zhiyuan1,Wang Wei1,Chen Zhongyuan1,Wu Yang1,Li Zesen1,Song Enlai1,Yue Xu1,Zhang Yongkang1,Li Wei1,Feng Youzhen1,Cao Donglin1,Zhang Dongmei1,Chen Minfeng1,Cai Xiangran1,Guan Bai-Ou1ORCID

Affiliation:

1. Jinan University

Abstract

Abstract

Efficient delivery of photons to visceral organs is critical for the treatment of deep-seated tumors taking advantage of photo-theranostics. Optical fiber can be regarded as a direct and facile photon pathway for targeting tumor lesion with negligible body invasion. However, current fiber theranostic strategies rely on the spatially separated optical fibers to realize diagnosis and therapy independently, resulting in low compactness, poor continuity of medical process, and incompatibility with current medical technologies. Herein, we develop an integrated fiber-optic theranostic (iFOT) probe that merges tumor microenvironment (TME) sensing and photothermal therapy (PTT) by functionalizing the fiber with graphene/gold nanostar hybrid materials and hypoxic-responsive fluorophores. The iFOT probe can quickly detect the hypoxia of xenograft tumors of mice with high sensitivity. The tumors can be photothermally killed on-site through the same fiber probe tightly followed by detection, which presents a high cure rate without the risk of recurrence. More importantly, the iFOT is highly adaptable to the conventional medical imaging and endoscopic techniques, such as laparoscope, magnetic resonance imaging, and ultrasound imaging, which facilitates the imaging-assisted navigation and manipulation by use of the interventional trocar. The proposed integrated fiber-optic theranostic strategy can be used as an effective endoscopic and interventional tool for tackling deep-situated tumor and may open a revolutionized pathway to bridge the separate diagnosis and therapy process in the current stage.

Publisher

Springer Science and Business Media LLC

Reference41 articles.

1. Rational combinations of targeted cancer therapies: background, advances and challenges;Jin H;Nature Reviews Drug Discovery,2023

2. Cancer statistics, 2023;Siegel RL;CA: a cancer journal for clinicians,2023

3. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA: a cancer journal for clinicians,2021

4. The ever-increasing importance of cancer as a leading cause of premature death worldwide;Bray F;Cancer,2021

5. The effects of surgery on tumor growth: a century of investigations;Demicheli R;Annals of oncology,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3